{"log_id": 3718030396852033728, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.000112, "average": 0.997007, "min": 0.939407}, "location": {"width": 826, "top": 154, "height": 56, "left": 238}, "words": "较高。不推荐酒精性肝炎患者使用本品治疗。患有中度到重度酒精性肝炎的患者"}, {"probability": {"variance": 0, "average": 0.999565, "min": 0.998692}, "location": {"width": 359, "top": 205, "height": 40, "left": 238}, "words": "使用本品治疗时,医生应谨慎使用"}, {"probability": {"variance": 0.00019, "average": 0.995744, "min": 0.924256}, "location": {"width": 777, "top": 255, "height": 53, "left": 282}, "words": "溶剂的预填充注射器橡皮塞中含有橡胶(干燥天然橡胶)。在接触或使用本"}, {"probability": {"variance": 4e-06, "average": 0.998841, "min": 0.99088}, "location": {"width": 826, "top": 302, "height": 55, "left": 233}, "words": "品之前,患者或护理人员应联系医生询问如何处置已知或可能对橡胶产生的超敏"}, {"probability": {"variance": 1e-06, "average": 0.999488, "min": 0.997766}, "location": {"width": 185, "top": 352, "height": 34, "left": 232}, "words": "反应(变态反应)"}, {"probability": {"variance": 2e-06, "average": 0.999125, "min": 0.996356}, "location": {"width": 146, "top": 401, "height": 29, "left": 230}, "words": "一般注意事项"}, {"probability": {"variance": 0, "average": 0.999924, "min": 0.999905}, "location": {"width": 50, "top": 449, "height": 25, "left": 228}, "words": "感染"}, {"probability": {"variance": 0.000537, "average": 0.994118, "min": 0.860823}, "location": {"width": 776, "top": 494, "height": 54, "left": 275}, "words": "由于本品的平均消除半衰期约为70小时(范围:7-300小时),因此在使用"}, {"probability": {"variance": 0, "average": 0.999569, "min": 0.997226}, "location": {"width": 671, "top": 541, "height": 50, "left": 223}, "words": "本品治疗前、治疗中和治疗后,必须对患者的感染情况进行评价"}, {"probability": {"variance": 0.000421, "average": 0.994621, "min": 0.885424}, "location": {"width": 782, "top": 588, "height": 58, "left": 267}, "words": "曾有使用本品发生严重感染、脓毒血症、结核病和机会病菌感染(包括侵"}, {"probability": {"variance": 0.000297, "average": 0.993537, "min": 0.902056}, "location": {"width": 805, "top": 633, "height": 62, "left": 220}, "words": "袭性真菌感染)的报告(参见“不良反应”)。这些感染是由细菌、分枝杆菌"}, {"probability": {"variance": 0.000969, "average": 0.990323, "min": 0.828219}, "location": {"width": 827, "top": 681, "height": 59, "left": 217}, "words": "真菌和病毒引起的。在某些情况下,由于真菌和其他机会致病菌不能被识别导致"}, {"probability": {"variance": 0.000455, "average": 0.993082, "min": 0.883248}, "location": {"width": 827, "top": 728, "height": 60, "left": 216}, "words": "治疗延误,有时导致死亡。在很多报告中,患者也同时使用包括免疫抑制剂在内"}, {"probability": {"variance": 0.020327, "average": 0.939807, "min": 0.354868}, "location": {"width": 830, "top": 772, "height": 68, "left": 212}, "words": "的药物治疗。在评估患者感染情况时,相并机致病菌对患者的风险也应考虑(如"}, {"probability": {"variance": 4e-06, "average": 0.998498, "min": 0.993553}, "location": {"width": 170, "top": 825, "height": 37, "left": 210}, "words": "地方性真菌病)。"}, {"probability": {"variance": 6e-05, "average": 0.99704, "min": 0.96051}, "location": {"width": 872, "top": 874, "height": 57, "left": 259}, "words": "需要对在本品治疗过程中出现新发感染的患者进行严密监测。如果患者出现"}, {"probability": {"variance": 2.3e-05, "average": 0.997746, "min": 0.982505}, "location": {"width": 294, "top": 918, "height": 46, "left": 207}, "words": "严重感染必须停止使用本品"}, {"probability": {"variance": 3e-06, "average": 0.998693, "min": 0.993741}, "location": {"width": 289, "top": 930, "height": 44, "left": 582}, "words": "慢性感染的患者使用本品的"}, {"probability": {"variance": 0.001021, "average": 0.959961, "min": 0.920231}, "location": {"width": 230, "top": 942, "height": 43, "left": 870}, "words": "安全性和有效"}, {"probability": {"variance": 0.010862, "average": 0.967853, "min": 0.431659}, "location": {"width": 829, "top": 965, "height": 63, "left": 207}, "words": "评估。复发性或慢性感染的者或存在可能导致患者易受感染的潜在条件(如晚"}, {"probability": {"variance": 0.000431, "average": 0.993308, "min": 0.89107}, "location": {"width": 728, "top": 1015, "height": 56, "left": 205}, "words": "期糖尿病或糖尿病控制不良),当考虑使用本品治疗时,应谨慎使用。"}, {"probability": {"variance": 4.5e-05, "average": 0.994366, "min": 0.982409}, "location": {"width": 132, "top": 1066, "height": 30, "left": 204}, "words": "结核病(TB"}, {"probability": {"variance": 0.000139, "average": 0.99443, "min": 0.950551}, "location": {"width": 784, "top": 1111, "height": 57, "left": 248}, "words": "已有报告使用TNF抑制剂(包括本品)的患者出现结核病,包括弥散性结"}, {"probability": {"variance": 1e-05, "average": 0.998957, "min": 0.981479}, "location": {"width": 794, "top": 1160, "height": 53, "left": 200}, "words": "核和肺外表现。结核病的出现可能是由于潜伏性结核感染的复发或新的感染"}, {"probability": {"variance": 3e-06, "average": 0.999006, "min": 0.990323}, "location": {"width": 779, "top": 1209, "height": 53, "left": 249}, "words": "在开始使用本品治疗前,必须对结核病风险高的患者进行活动性或潜伏性结"}, {"probability": {"variance": 1.6e-05, "average": 0.998414, "min": 0.975849}, "location": {"width": 830, "top": 1255, "height": 54, "left": 196}, "words": "核感染的评估。该评估包括结核病患者的个人信息及详细医疗史、以往与结核病"}, {"probability": {"variance": 6e-06, "average": 0.998776, "min": 0.985526}, "location": {"width": 835, "top": 1303, "height": 54, "left": 193}, "words": "人的接触史和以往和或目前的免疫抑制治疗法。所有患者需进行恰当的筛选试"}, {"probability": {"variance": 0.000184, "average": 0.996226, "min": 0.919367}, "location": {"width": 831, "top": 1351, "height": 54, "left": 193}, "words": "验,例如结合菌素皮肤试验及胸部X线检查(可以参考当地推荐的方法)。处方"}, {"probability": {"variance": 1.8e-05, "average": 0.998847, "min": 0.974459}, "location": {"width": 830, "top": 1399, "height": 53, "left": 191}, "words": "医生应注意结核菌素皮肤试验出现假阴性的结果,特别是那些患有严重疾病或免"}, {"probability": {"variance": 0, "average": 0.999619, "min": 0.999077}, "location": {"width": 151, "top": 1448, "height": 32, "left": 189}, "words": "疫缺陷的患者"}, {"probability": {"variance": 5e-06, "average": 0.99886, "min": 0.989982}, "location": {"width": 771, "top": 1495, "height": 51, "left": 238}, "words": "如果患者确诊为活动性结核感染,则禁止使用本品治疗。在本品开始治疗前"}], "language": 3}